COLUMBUS, Ohio – Dr. Carlo Croce, chair of the department of molecular virology, immunology, and medical genetics; and director of Human Cancer Genetics at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James), is among 106 scientists selected by the American Association for Cancer Research to be in the first class of the Fellows of the AACR Academy.
AACR will inaugurate the first class of Fellows at the AACR Annual Meeting 2013, to be held in Washington, D.C., April 6-10.
The new AACR Academy recognizes and honors distinguished scientists whose major scientific contributions have propelled significant innovation and progress against cancer. These Fellows have been selected through a rigorous peer review process that evaluates individuals on the basis of their stellar scientific achievements in cancer research.
“Our Board of Directors made the decision to establish the AACR Academy as a mechanism for recognizing scientists whose contributions to the cancer field have had an extraordinary impact. Membership in the Fellows of the AACR Academy will be the most prestigious honor bestowed by the American Association for Cancer Research,” said Margaret Foti, Ph.D., M.D., chief executive officer of the AACR.
Croce, also the John W. Wolfe Chair in Human Cancer Genetics, has previously received one of the nation’s highest honors with his induction as a member of the Institute of Medicine of the National Academies.
Croce, a member of the National Academy of Sciences in the United States and the Accademia Nazionale delle Scienze detta dei XL in Italy, has received numerous awards for cancer research. He is principal investigator on 11 federal research grants and has more than 900 peer-reviewed, published research papers.
The Fellows of the AACR Academy is a separate entity within the American Association for Cancer Research, and only individuals who have made exceptional contributions to cancer and/or cancer-related biomedical science are eligible for election. The inaugural class of Fellows will be inducted into the AACR Academy on Friday, April 5, at the National Museum of Women in the Arts in Washington, D.C., at 6:30 p.m.
The induction ceremony will be followed by a meeting of the Academy on Saturday, April 6, and special recognition of the inaugural Fellows during the opening plenary session on Sunday, April 7. These events will be annual occurrences at future AACR Annual Meetings.
The inaugural class of Fellows of the AACR Academy will consist of 106 individuals, symbolizing the age of the organization upon establishment of the Academy. Future classes of Fellows shall consist of no more than 11 individuals, in honor of the 11 founding members of the American Association for Cancer Research. These Fellows will be elected by a vote of all the Fellows of the AACR Academy.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State’s cancer program as “exceptional,” the highest rating given by NCI survey teams. As the cancer program’s 228-bed adult patient-care component, The James is a “Top Hospital” as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S. News & World Report.
# # #
Click here for a high-resolution photo of Dr. Carlo Croce.
Contact: Eileen Scahill, Wexner Medical Center Public Affairs and Media Relations, 614-293-3737, or Eileen.Scahill@osumc.edu